• OPEN AN ACCOUNT
Indian Indices
Nifty
24,718.60 -169.60
(-0.68%)
Sensex
81,118.60 -573.38
( -0.70%)
Bank Nifty
55,527.35 -555.20
( -0.99%)
Nifty IT
38,469.25 8.95
( 0.02%)
Global Indices
Nasdaq
42,214.73 -773.90
(-1.80%)
Dow Jones
5,997.34 -68.92
(-1.14%)
Hang Seng
37,801.43 -371.66
(-0.97%)
Nikkei 225
8,850.63 -34.29
(-0.39%)
Forex
USD-INR
85.55 0.07
(0.08%)
EUR-INR
98.89 0.98
(1.00%)
GBP-INR
116.24 0.70
(0.61%)
JPY-INR
0.60 0.01
(0.86%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
345.7902301
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
21.24
113614.8
EPS(TTM)
Face Value()
Div & Yield %
64.1
1
0.59
 

Trident spurts after Q4 PAT climbs 135% YoY to Rs 133 cr
May 21,2025
Profit before tax stood at Rs 171.71 crore in the March 2025 quarter, up 119.71% on YoY basis.

The firm’s revenue from yarn business stood at Rs 908.28 crore (up 0.69% YoY) and revenue from towel business was at Rs 752.86 crore (up 30.84%).

Further, revenue from bedsheets segment was at Rs 315.14 crore (up 4.04% YoY) and revenue from paper and chemicals business stood at Rs 268.39 crore (down 4.35% YoY) during the period under review.

On a standalone basis, the company’s net profit soared 105.39% to Rs 131.84 crore on 10.74% decline in revenue from operations to Rs 1,859.45 crore in Q4 FY25 over Q4 FY24.

On a full-year basis, the company's consolidated net profit rose 5.82% to Rs 369.88 crore on 2.61% increase in revenue from operations to Rs 6,987.08 crore in FY25 over FY24.

The company’s board has declared a 1st interim dividend of Rs 0.50 per fully paid-up equity share for the financial year 2025-26.

Trident is one of the largest towel manufacturers in the world, one of the world's largest agro–based paper manufacturers and one of the largest yarn producers in India. Trident is a vertically integrated textile (yarn, bath & bed linen) and paper (wheat straw-based) manufacturer.